---
figid: PMC9437236__CNS-28-1539-g001
pmcid: PMC9437236
image_filename: CNS-28-1539-g001.jpg
figure_link: /pmc/articles/PMC9437236/figure/cns13895-fig-0001/
number: FIGURE 1
figure_title: ''
caption: There were negative associations between the baseline Methyl n‐formylanthranilate
  levels and the reduction rate in the positive subscore or PANSS total score in FEDN
  patients after 4 weeks of olanzapine monotherapy (all p < 0.05). The red line is
  the trend line and the black dashed line is the 95% confidence interval
article_title: 'Kynurenine pathway metabolites and therapeutic response to olanzapine
  in female patients with schizophrenia: A longitudinal study.'
citation: Xiaoni Guan, et al. CNS Neurosci Ther. 2022 Oct;28(10):1539-1546.
year: '2022'

doi: 10.1111/cns.13895
journal_title: CNS Neuroscience & Therapeutics
journal_nlm_ta: CNS Neurosci Ther
publisher_name: John Wiley and Sons Inc.

keywords:
- kynurenine
- metabolite
- olanzapine
- schizophrenia
- therapeutic response

---
